Drug Profile

Somatotropin biobetter - Ahn-Gook Pharma

Alternative Names: AG-B1512

Latest Information Update: 28 Dec 2024

Price :

$50 ^*

Note:

Adis is an information provider. We do not sell or distribute actual drugs.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

Originator Ahn-Gook Pharmaceutical
Class Biobetters; Growth hormones; Hormonal replacements
Mechanism of Action Somatotropin receptor agonists

Orphan Drug Status

Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

No
New Molecular Entity Yes

Highest Development Phases

No development reported Growth disorders

Most Recent Events

28 Dec 2024 No recent reports of development identified for phase-I development in Growth-disorders in South Korea (IV, Injection)
28 Dec 2024 No recent reports of development identified for phase-I development in Growth-disorders in South Korea (SC, Injection)
01 Nov 2021 Phase-I clinical trials in Growth disorders in South Korea (IV) (Ahn-Gook Pharmaceutical pipeline, November 2021)

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com